Bangkok Dusit Medical Services PCL
SET:BDMS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nanjing Xinlian Electronics Co Ltd
SZSE:002546
|
CN |
|
Corbion NV
AEX:CRBN
|
NL |
|
S
|
Sarthak Industries Ltd
BSE:531930
|
IN |
|
C
|
CK Asset Holdings Ltd
SWB:1CK
|
HK |
|
Vox Royalty Corp
TSX:VOXR
|
CA |
|
X
|
Xpeng Inc
HKEX:9868
|
CN |
|
Kanabo Group PLC
LSE:KNB
|
UK |
|
M
|
MySale Group PLC
LSE:MYSL
|
AU |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its 3-Year Average (22.1), the stock would be worth ฿27.42 (47% upside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 15.1 | ฿18.7 |
0%
|
| 3-Year Average | 22.1 | ฿27.42 |
+47%
|
| 5-Year Average | 24.6 | ฿30.5 |
+63%
|
| Industry Average | 12.2 | ฿15.1 |
-19%
|
| Country Average | 11.7 | ฿14.47 |
-23%
|
Forward EV/EBIT
Today’s price vs future ebit
| Today's Enterprise Value | EBIT | Forward EV/EBIT | ||
|---|---|---|---|---|
|
฿312B
|
/ |
Jan 2026
฿20.2B
|
= |
|
|
฿312B
|
/ |
Dec 2026
฿22.4B
|
= |
|
|
฿312B
|
/ |
Dec 2027
฿22.1B
|
= |
|
|
฿312B
|
/ |
Dec 2028
฿24.1B
|
= |
|
Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| TH |
B
|
Bangkok Dusit Medical Services PCL
SET:BDMS
|
297.2B THB | 15.1 | 18.8 | |
| US |
|
HCA Healthcare Inc
NYSE:HCA
|
111.4B USD | 12.5 | 16.4 | |
| SA |
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
98B SAR | 40 | 40.8 | |
| ZA |
N
|
Netcare Ltd
JSE:NTC
|
24.1B ZAR | 9.5 | 14.3 | |
| MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
76.9B MYR | 22.5 | 36.6 | |
| ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
18B ZAR | -53.3 | 4.6 | |
| BR |
|
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
86.6B BRL | 9.5 | 18.8 | |
| US |
|
Tenet Healthcare Corp
NYSE:THC
|
17.1B USD | 7.2 | 12.2 | |
| CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
89.3B CNY | 19.9 | 27.8 | |
| IN |
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
1.1T INR | 42.3 | 60.4 | |
| US |
|
Ensign Group Inc
NASDAQ:ENSG
|
11.6B USD | 26 | 33.4 |
Market Distribution
| Min | 0.4 |
| 30th Percentile | 8.7 |
| Median | 11.7 |
| 70th Percentile | 15.7 |
| Max | 2 524.8 |
Other Multiples
Bangkok Dusit Medical Services PCL
Glance View
Bangkok Dusit Medical Services PCL (BDMS) stands as a beacon of healthcare excellence in Thailand, playing a crucial role in providing comprehensive medical care since its inception. Founded in 1969, BDMS has steadily expanded its footprint to become one of the largest private hospital operators in the region. Anchored in Bangkok, the heart of Thailand's urban landscape, the company operates a network of hospitals across Southeast Asia. With a portfolio that includes several specialized centers and well-established hospital brands like Bangkok Hospital, Samitivej, and BNH Hospital, BDMS caters to a diverse patient base ranging from local and international patients to expatriates. The company's business model revolves around leveraging a mix of advanced medical technology and a highly skilled medical workforce to offer a wide range of healthcare services, from routine check-ups and wellness programs to complex surgical procedures. Financially, BDMS derives its revenue through various healthcare services, taking advantage of Thailand's growing reputation as a premier destination for medical tourism. The company earns from patient consultations, diagnostic services, surgical procedures, and inpatient care. A signature of BDMS's approach has been its investment in cutting-edge medical equipment and continuous medical education, which keeps its service quality at par with international standards. Additionally, the group's proactive expansion strategy, incorporating acquisitions and the development of specialty centers, has secured its leadership status in the healthcare sector. This well-orchestrated blend of strategic expansion and diversified service offerings ensures a steady stream of revenue and bolsters BDMS's position as a cornerstone of private healthcare in the region.